Login to Your Account

U.S. Patent Disclosures

Monday, October 17, 2011
Cortex Pharmaceuticals Inc., of Irvine, Calif., received a notice of allowance for a patent protecting the use of Ampakine molecules for treating or preventing respiratory depression.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription